- Austria / Österreich
- Bosnia and Herzegovina / Босна и Херцеговина
- Bulgaria / България
- Croatia / Hrvatska
- Czech Republic & Slovakia / Česká republika & Slovensko
- France / France
- Germany / Deutschland
- Greece / ΕΛΛΑΔΑ
- Italy / Italia
- Netherlands / Nederland
- Nordic / Nordic
- Poland / Polska
- Portugal / Portugal
- Romania & Moldova / România & Moldova
- Slovenia / Slovenija
- Serbia & Montenegro / Србија и Црна Гора
- Spain / España
- Switzerland / Schweiz
- Turkey / Türkiye
- UK & Ireland / UK & Ireland
BASEL, Switzerland: Continuing on from a strong 2017, the Straumann Group has reported a positive start to the first quarter of 2018. With double-digit expansion in implants, the group’s largest business, as well as growth in its restorative and digital businesses, the Basel-based company also won market share with its premium products, such as Bone Level Tapered, Roxolid and SLActive implants, and expanded the reach of some its non-premium brands.
Commenting on the positive developments, CEO Marco Gadola said Straumann was benefitting from the addition of its digital and orthodontics businesses, which he predicts will support further growth going forward.
The group’s largest regions, Europe, the Middle East and Africa, grew well, despite fewer business days in central Europe owing to the Easter break. According to Straumann, organic growth amounted to 10 per cent, with a further 3 per cent points added through the consolidation of Dental Wings and Batigroup, a distribution company in Turkey that Straumann recently acquired. These factors and a stronger euro contributed to an overall increase of 21 per cent in Swiss francs, bringing regional revenue to CHF147 million.
In addition to strong regional growth and in a move to keep pace with technological developments in dentistry, Straumann recently announced that it had acquired a small stake in Dental Monitoring, which offers a remote dental monitoring system that uses smartphones and artificial intelligence to improve treatment efficiency. The Straumann Group believes this technology could support the full spectrum of its activities and the two companies will collaborate to develop further applications in the future.
“Based on this good start, we are in good shape to deliver low double-digit growth over the full year, together with the profitability targets that we communicated in February,” said Gadola.
Tags:
Fri. 26 April 2024
12:00 pm EST (New York)
How you can access data-driven decision making
Wed. 22 May 2024
12:00 pm EST (New York)
Leveraging the TLX implant concept in fast and efficient treatment protocols
Wed. 29 May 2024
5:00 am EST (New York)
Treatment of periimplantitis: Electro-chemical cleaning of the implant
Thu. 7 November 2024
12:00 pm EST (New York)
Leveraging the TLX ProArch concept in fully digital workflows to provide efficient full-arch rehabilitations with optimal peri-implant health
webinar
Precision in practice: Elevating clinical communication
webinar
To post a reply please login or register